Match!
Gus Gazzard
UCL Institute of Ophthalmology
OphthalmologySurgeryGlaucomaPopulationMedicine
137Publications
39H-index
4,446Citations
What is this?
Publications 147
Newest
#1Hari Jayaram (UCL Institute of Ophthalmology)H-Index: 12
#2Nicholas G. Strouthidis (UCL Institute of Ophthalmology)H-Index: 29
Last. Gus Gazzard (UCL Institute of Ophthalmology)H-Index: 39
view all 3 authors...
1 CitationsSource
#1Lee Jones (UCL: University College London)
Last. Gus Gazzard (UCL: University College London)H-Index: 39
view all 3 authors...
Introduction In the UK, the National Institute for Health and Clinical Excellence are amending guidelines to support use of selective laser trabeculoplasty (SLT) as a first-line treatment for patients with glaucoma and ocular hypertension. The procedure is quick, effective in lowering intraocular pressure, cost-effective for the National Health Service and offers an equivalent safety profile to other therapies. The procedure is typically performed by an ophthalmologist; however, there is potenti...
Source
#1David Wright ('QUB': Queen's University Belfast)H-Index: 14
#2Evgenia Konstantakopoulou (UCL: University College London)H-Index: 3
view all 9 authors...
Abstract Objective To compare visual field outcomes of ocular hypertensive and glaucoma patients treated with Medicine-1st against those treated with selective laser trabeculoplasty (SLT, Laser-1st). Design Secondary analysis of patients from Laser in Glaucoma and Ocular Hypertension (LiGHT), a multicentre randomised controlled trial. Participants and controls 344 patients (588 eyes) treated with Medicine-1st, 344 patients (590 eyes) treated with Laser-1st. Methods Visual fields (VFs) were measu...
Source
#1Anurag Garg (UCL Institute of Ophthalmology)
#1Anurag Garg (UCL: University College London)H-Index: 2
Last. Gus Gazzard (UCL: University College London)H-Index: 39
view all 10 authors...
Abstract Purpose To determine the efficacy of repeat selective laser trabeculoplasty (SLT) in medication-naive open angle glaucoma (OAG) and ocular hypertensive (OHT) patients requiring repeat treatment for early to medium-term failure during the Laser in Glaucoma and Ocular Hypertension (LiGHT) trial. Design Post-hoc analysis of SLT treatment arm of a multicentre prospective randomised-controlled-trial. Participants Treatment-naive OAG or OHT requiring repeat 360-degree SLT within 18 months. Re...
Source
#1Bryan C H Ang (National Healthcare Group)
#2Sophia Seen (NUS: National University of Singapore)H-Index: 2
Last. Tin AungH-Index: 75
view all 11 authors...
Background/Aims This work aimed to study the effect of long-term intraocular pressure (IOP) fluctuation on visual field (VF) progression 8 years post-trabeculectomy in Asian eyes. Methods This was a retrospective analysis of 8-year post-trabeculectomy data from The Singapore 5-Fluorouracil (5-FU) Study. VFs were analysed using Progressor software (Medisoft, Leeds, UK). Outcome measures included mean slope for VF per year, number of progressing points and mean slope for progressing points per yea...
Source
#1Reena Chopra (UCL Institute of Ophthalmology)H-Index: 5
Last. Pearse A. Keane (UCL Institute of Ophthalmology)H-Index: 34
view all 8 authors...
#1Luke Tanner (University of Exeter)
#2Gus Gazzard (UCL Institute of Ophthalmology)H-Index: 39
Last. Paul J. Foster (UCL Institute of Ophthalmology)H-Index: 64
view all 4 authors...
Angle-closure glaucoma is an aggressive condition that causes millions to become blind worldwide. This review explores the use of prophylactic laser peripheral iridotomy (PI) in patients classified as primary angle-closure suspects (PACS), and additionally, the use of clear lens exchange as a primary treatment option in established angle-closure disease with or without glaucoma. As PI has a strong prophylactic effect in fellow eyes of patients who have had an acute attack, its use has been widel...
Source
#1Anurag Garg (UCL Institute of Ophthalmology)
#2Gus Gazzard (UCL Institute of Ophthalmology)H-Index: 39
Despite advances in our knowledge of the aetiology and pathophysiology of glaucoma, the sole proven, effective intervention for treating primary open-angle glaucoma (POAG) and ocular hypertension (OHT) remains lowering of intraocular pressure (IOP) to prevent further progression and visual loss. The purpose of this review is to evaluate the treatment choices available to newly diagnosed POAG and OHT patients. We review the existing literature on treatments currently available to newly diagnosed ...
Source
#1Anurag Garg (UCL Institute of Ophthalmology)
#2Gus Gazzard (UCL Institute of Ophthalmology)H-Index: 39
Last. G. Gazzard (UCL Institute of Ophthalmology)H-Index: 1
view all 2 authors...
Source
#1Anurag Garg (UCL Institute of Ophthalmology)H-Index: 2
#2Victoria Vickerstaff (UCL: University College London)H-Index: 11
Last. Haogang ZhuH-Index: 12
view all 25 authors...
Purpose To report clinical efficacy, predictors of success, and safety of primary selective laser trabeculoplasty (SLT) used in treatment-naive patients with open-angle glaucoma (OAG) or ocular hypertension (OHT). Design Post hoc analysis of a multicenter, prospective, randomized, controlled trial. Participants Treatment-naive patients with OAG or OHT. Methods Patients randomized to SLT or topical medication and treated to predefined target intraocular pressures (IOPs) requiring ≥20% IOP reducti...
2 CitationsSource
12345678910